327 related articles for article (PubMed ID: 14964758)
21. Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.
Berman B; Nestor MS; Newburger J; Park H; Swenson N
J Drugs Dermatol; 2014 Nov; 13(11):1353-6. PubMed ID: 25607702
[TBL] [Abstract][Full Text] [Related]
22. Randomized, double-blind, placebo-controlled prospective study of the efficacy of topical anaesthesia with a eutetic mixture of lignocaine 2.5% and prilocaine 2.5% for topical 5-aminolaevulinic acid-photodynamic therapy for extensive scalp actinic keratoses.
Langan SM; Collins P
Br J Dermatol; 2006 Jan; 154(1):146-9. PubMed ID: 16403108
[TBL] [Abstract][Full Text] [Related]
23. ALA-PDT and blue light therapy for hidradenitis suppurativa.
Gold M; Bridges TM; Bradshaw VL; Boring M
J Drugs Dermatol; 2004; 3(1 Suppl):S32-5. PubMed ID: 14964759
[TBL] [Abstract][Full Text] [Related]
24. A randomized, blinded, bilateral intraindividual, vehicle-controlled trial of the use of photodynamic therapy with 5-aminolevulinic acid and blue light for the treatment of actinic keratoses of the upper extremities.
Taub AF; Garretson CB
J Drugs Dermatol; 2011 Sep; 10(9):1049-56. PubMed ID: 22052276
[TBL] [Abstract][Full Text] [Related]
25. Effect of retinoid pretreatment on outcomes of patients treated by photodynamic therapy for actinic keratosis of the hand and forearm.
Galitzer BI
J Drugs Dermatol; 2011 Oct; 10(10):1124-32. PubMed ID: 21968662
[TBL] [Abstract][Full Text] [Related]
26. Photodynamic effectiveness and vasoconstriction in hairless mouse skin after topical 5-aminolevulinic acid and single- or two-fold illumination.
van der Veen N; Hebeda KM; de Bruijn HS; Star WM
Photochem Photobiol; 1999 Dec; 70(6):921-9. PubMed ID: 10628304
[TBL] [Abstract][Full Text] [Related]
27. Photodynamic therapy using a novel photosensitizer, ATX-S10(Na): comparative effect with 5-aminolevulinic acid on squamous cell carcinoma cell line, SCC15, ultraviolet B-induced skin tumor, and phorbol ester-induced hyperproliferative skin.
Takahashi H; Nakajima S; Sakata I; Ishida-Yamamoto A; Iizuka H
Arch Dermatol Res; 2005 Apr; 296(10):496-502. PubMed ID: 15759135
[TBL] [Abstract][Full Text] [Related]
28. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin.
Wiegell SR; Stender IM; Na R; Wulf HC
Arch Dermatol; 2003 Sep; 139(9):1173-7. PubMed ID: 12975159
[TBL] [Abstract][Full Text] [Related]
29. Topical aminolevulinic acid-photodynamic therapy for the treatment of acne vulgaris.
Hong SB; Lee MH
Photodermatol Photoimmunol Photomed; 2005 Dec; 21(6):322-5. PubMed ID: 16313244
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the chemopreventative effects of ALA PDT in patients with multiple actinic keratoses and a history of skin cancer.
Goldberg LH; Landau JM; Moody MN; Marquez D; Jih M; Kimyai-Asadi A; Friedman PM; Busch A; Vergilis-Kalner IJ
J Drugs Dermatol; 2012 May; 11(5):593-7. PubMed ID: 22527427
[TBL] [Abstract][Full Text] [Related]
31. [Topical photodynamic therapy in dermatology].
Grob M; Schmid-Grendelmeier P
Ther Umsch; 1998 Aug; 55(8):529-32. PubMed ID: 9757821
[TBL] [Abstract][Full Text] [Related]
32. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.
Itkin A; Gilchrest BA
Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801
[TBL] [Abstract][Full Text] [Related]
33. Photodynamic therapy using a novel photosensitizer, TONS501, is similarly effective to ALA and EC036 photodynamic therapy on DMBA-and TPA-induced mouse skin papilloma.
Takahashi H; Nakajima S; Asano R; Nakae Y; Sakata I; Iizuka H
J Dermatol Sci; 2012 Jun; 66(3):221-4. PubMed ID: 22464765
[TBL] [Abstract][Full Text] [Related]
34. Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma.
Campbell SM; Morton CA; Alyahya R; Horton S; Pye A; Curnow A
Br J Dermatol; 2008 Aug; 159(2):387-93. PubMed ID: 18544077
[TBL] [Abstract][Full Text] [Related]
35. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
[TBL] [Abstract][Full Text] [Related]
36. Pain during topical photodynamic therapy of actinic keratoses with 5-aminolevulinic acid and red light source: randomized controlled trial.
Buinauskaite E; Zalinkevicius R; Buinauskiene J; Valiukeviciene S
Photodermatol Photoimmunol Photomed; 2013 Aug; 29(4):173-81. PubMed ID: 23815349
[TBL] [Abstract][Full Text] [Related]
37. Current treatments of actinic keratosis.
Gold MH; Nestor MS
J Drugs Dermatol; 2006 Feb; 5(2 Suppl):17-25. PubMed ID: 16485877
[TBL] [Abstract][Full Text] [Related]
38. Aminolevulinic acid photodynamic therapy for actinic keratoses/actinic cheilitis/acne: vascular lasers.
Alexiades-Armenakas M
Dermatol Clin; 2007 Jan; 25(1):25-33. PubMed ID: 17126739
[TBL] [Abstract][Full Text] [Related]
39. Our PDT experience in the treatment of non-melanoma skin cancer over the last 7 years.
Baptista J; Martinez C; Leite L; Cochito M
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):693-7. PubMed ID: 16836497
[TBL] [Abstract][Full Text] [Related]
40. Topical photodynamic therapy is immunosuppressive in humans.
Matthews YJ; Damian DL
Br J Dermatol; 2010 Mar; 162(3):637-41. PubMed ID: 19863500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
